Endpoints News 生物医药· ENDPOINTS·· 4 天前AI 评分30
中国大幅降价 CAR-T 治疗
China's $40k CAR-T; Novartis and Biogen strike deals
AI 导读
中国大幅降低 CAR-T 治疗费用,价格降至 4 万元人民币。该疗法已在中国获批用于特定血液肿瘤。
正文
Plus, news about Amylyx, Jiangsu Hengrui and AstraZeneca.
China drastically cuts price of a CAR-T: China is adding a CAR-T therapy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news